Inventor · disambiguated record
Robert Gurny
Also filed as: GURNY ROBERT
22 granted patents·12 pending applications·324 citations·filing 1988–2019
94Inventor score
Files withUNIV GENEVE8DEBIO RECH PHARMA SA2ESBATECH - A NOVARTIS COMPANY LLC2ESBATECH A NOVARTIS CO LLC2GURNY ROBERT2
Top patents by PatentIndex Score
34 records- 0188US5773021ABioadhesive ophthalmic insertVETOQUINOL SA·Filed 1996·Granted Jun 30, 1998·143 cites·11 claims
- 0287US8741877B2Polylactides compositions and uses thereofUNIV GENEVE·Filed 2013·Granted Jun 3, 2014·9 cites·40 claims
- 0381US4968350AProcess for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereofBINDSCHAEDLER CHRISTIAN·Filed 1988·Granted Nov 6, 1990·57 cites·10 claims
- 0476US8466133B2Polylactides compositions and uses thereofMOLLER MICHAEL·Filed 2006·Granted Jun 18, 2013·4 cites·23 claims
- 0575US9873736B2Protein sustained-release injectable formulationESBATech—a Novartis Company LLC·Filed 2014·Granted Jan 23, 2018·1 cites·2 claims
- 0673US6319512B1Implants for controlled release of pharmaceutically active principles and method for making sameDEBIO RECH PHARMA SA·Filed 1998·Granted Nov 20, 2001·43 cites·11 claims
- 0771US8507563B2Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the sameBERGER JEROME·Filed 2009·Granted Aug 13, 2013·1 cites·7 claims
- 0869US7455858B2Compositions and methods for delivery of photosensitive drugsQUADRA LOGIC TECH INC·Filed 2003·Granted Nov 25, 2008·4 cites·19 claims
- 0967US6589999B2Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous mediaMEDIDOM LAB·Filed 2001·Granted Jul 8, 2003·7 cites·17 claims
- 1063US10314913B2Polylactide compositions and uses thereofUNIV GENEVE·Filed 2018·Granted Jun 11, 2019·0 cites·23 claims
- 1163US9375482B2Polylactide compositions and uses thereofUNIV GENEVE·Filed 2014·Granted Jun 28, 2016·0 cites·31 claims
- 1262US6440460B1Pharmaceutical compositions containing buffered ortho ester polymersALLERGAN SALES INC·Filed 1997·Granted Aug 27, 2002·33 cites·8 claims
- 1359US2007275969A1Nanoparticles for oral administration of pharmaceutical agents of low solubilityGURNY ROBERT·Filed 2007·Application pending·0 cites
- 1458US9925267B2Polylactide compositions and uses thereofUNIV GENEVE·Filed 2016·Granted Mar 27, 2018·0 cites·19 claims
- 1558US2013202605A1Protein sustained-release injectable formulationESBATECH A NOVARTIS CO LLC·Filed 2013·Application pending·0 cites
- 1657US2004018236A1Nanoparticles for oral administration of pharmaceutical agents of low solubilityFiled 2003·Application pending·0 cites
- 1756US10093726B2Protein sustained-release injectable formulationESBATech—a Novartis Company LLC·Filed 2016·Granted Oct 9, 2018·0 cites·1 claims
- 1856US2018362630A1Protein sustained-release injectable formulationESBATECH A NOVARTIS CO LLC·Filed 2018·Application pending·0 cites
- 1955US9468683B2Hybrid hydrogelsUNIV GENEVE·Filed 2013·Granted Oct 18, 2016·0 cites·45 claims
- 2055US8945609B2Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the sameSCHUETZ YANNIC·Filed 2005·Granted Feb 3, 2015·2 cites·12 claims
- 2155US6245346B1Pharmaceutical compositions for the sustained release of insoluble active principlesDEBIO RECH PHARMA SA·Filed 1997·Granted Jun 12, 2001·18 cites·38 claims
- 2254US9155745B2Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugsGURNY ROBERT·Filed 2010·Granted Oct 13, 2015·2 cites·19 claims
- 2350US2013281638A1Tricyclo compound-polymer conjugateSUCAMPO AG·Filed 2013·Application pending·0 cites
- 2449US2021038563A1New spironolactone formulations and their useAPIDEL SA·Filed 2019·Application pending·0 cites
- 2546US2009130176A1Intraocular lens with drug delivery system attached theretoBOSSY-NOBS LEILA·Filed 2007·Application pending·0 cites
- 2646US2015306237A1Hyaluronic acid-antioxidant conjugates and their usesUNIV GENEVE·Filed 2013·Application pending·0 cites
- 2745US2014335135A1Pharmaceutical compositionFERRING BV·Filed 2012·Application pending·0 cites
- 2843US8835571B2Fatty acid derivative-polymer conjugateSUCAMPO AG·Filed 2013·Granted Sep 16, 2014·0 cites·29 claims
- 2939US8835514B2Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the sameBERGER JÉRÔME·Filed 2004·Granted Sep 16, 2014·0 cites·4 claims
- 3036US9549985B2Compositions comprising polymers prepared from 2-hydroxyalkyl acidsMOELLER MICHAEL·Filed 2010·Granted Jan 24, 2017·0 cites·13 claims
- 3131US2013028920A1Stabilized antibody preparations and uses thereofUNIV GENEVE·Filed 2011·Application pending·0 cites
- 3231US2014163217A1Process for the esterification of hyaluronic acid with hydrophobic organic compoundsMOELLER MICHAEL·Filed 2011·Application pending·0 cites
- 3331US2013017197A1Stabilized antibody preparations and uses thereofUNIV GENEVE·Filed 2011·Application pending·0 cites
- 3421US9055722B2Product for use in agriculture or horticultureZIMMERMANN DIANE·Filed 2002·Granted Jun 16, 2015·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →